Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Ribonucleic Acid (RNA) Sequencing Market Size From 2025 to 2034?
There has been an exponential growth in the size of the ribonucleic acid (rna) sequencing market in the past few years. The market is projected to escalate from a worth of $3.25 billion in 2024 to approximately $3.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 21.8%. The notable growth observed in the past can be credited to the upsurge in drug development activities, increased incidence of genetic disorders and targeted diseases, the rising utilization of compact portable devices, the growing application of biomarker profiling, rising demand for personalized medicine, and the mounting number of cancer cases.
Anticipated to experience significant expansion in the coming years, the ribonucleic acid (rna) sequencing market size is projected to reach$8.34 billion by 2029, with a compound annual growth rate (CAGR) of 20.5%. The growth trajectory during the forecast period could be attributed to several factors such as the burgeoning demand for swift and precise disease diagnosis, increasing usage of real-time polymerase chain reaction, the escalating need for quick and on-site diagnostic testing, an upsurge in infectious disease incidents, and a growing demand for companion diagnostics. In the forecasted period, significant market trends would involve disease detection and monitoring, drug discovery, target validation, the identification of biomarkers, advancements in DNA sequencing technologies, enhancement in diagnostic testing approaches, the emergence of next-generation sequencing (NGS), microfluidics, the advent of lab-on-a-chip platforms, and progress in advanced molecular diagnostic solutions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp
What are the Fundamental Drivers and Innovations Shaping the Ribonucleic Acid (RNA) Sequencing Market?
The projected growth of the ribonucleic acid (RNA) sequencing market is owed to an intensified concentration on precision medicine. This cutting-edge medical treatment and prevention method factors in the individual divergences in genes, environment, and lifestyle for each individual. By offering superiorly effective treatments, advancing genomics, escalating disease complexity, and enjoying regulatory endorsement, personalized medicine holds much promise. RNA sequencing technologies, used for determining sequence and gauging the expression levels of RNA molecules within a sample, allow for in-depth scrutiny of transcriptomes, shedding light on gene expression patterns, alternative splicing events, and RNA modifications. For example, the Personalized Medicine Coalition, a non-profit group based in the US, reported in February 2024 that the FDA had given the thumbs-up to 16 new personalized therapies for patients with rare diseases in 2023, a steep increase from six in 2022. As such, the rising emphasis on precision medicine is propelling the ribonucleic acid (RNA) sequencing market forward.
How Is the Ribonucleic Acid (RNA) Sequencing Market Segmented?
The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –
1) By Product Type: Instruments; Reagents And Kits; Software
2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits
3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp
Which Regions Are Driving the Next Phase of the Ribonucleic Acid (RNA) Sequencing Market Growth?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Ribonucleic Acid (RNA) Sequencing Market?
Significant businesses in the ribonucleic acid (RNA) sequencing industry are concentrating their efforts on RNA next-generation sequencing assays to enhance patient treatment through intelligent data analysis and precision medicine. The RNA next-generation sequencing assay, a cutting-edge exome sequencing system, utilizes revolutionary genomic sequencing techniques to examine a patient’s entire exome. For example, in June 2023, the American precision medicine technology firm Tempus introduced Tempus xR, a fresh standalone RNA next-generation sequencing assay. Tailored for solid tumors, this groundbreaking assay undertakes a comprehensive review of the full transcriptome, marking clinically relevant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. Tempus xR appeals to medical professionals particularly interested in RNA fusions or altered splicing, and to providers, investigators, and biopharmaceutical firms requiring detailed RNA sequencing examination of their available samples.
View the full report here:
How Is the Ribonucleic Acid (RNA) Sequencing Market Defined and What Are Its Core Parameters?
Ribonucleic acid (RNA) sequencing refers to a technique that uses next-generation sequencing to reveal the presence and quantity of RNA molecules in a biological sample, providing a snapshot of gene expression in the sample. It enables researchers to study gene expression, identify novel transcripts, and understand RNA processing.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model